GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $97,000 | -1.0% | 2,229 | +0.5% | 0.01% | +16.7% |
| Q4 2021 | $98,000 | +4.3% | 2,219 | -5.3% | 0.01% | -14.3% |
| Q2 2021 | $94,000 | -19.0% | 2,344 | -28.2% | 0.01% | -22.2% |
| Q1 2021 | $116,000 | -40.5% | 3,264 | -38.3% | 0.01% | -43.8% |
| Q4 2020 | $195,000 | -2.0% | 5,294 | 0.0% | 0.02% | -11.1% |
| Q3 2020 | $199,000 | -7.4% | 5,294 | +0.5% | 0.02% | -14.3% |
| Q2 2020 | $215,000 | -10.8% | 5,269 | -17.2% | 0.02% | -8.7% |
| Q1 2020 | $241,000 | -18.3% | 6,366 | +1.6% | 0.02% | +4.5% |
| Q4 2019 | $295,000 | +19.0% | 6,266 | +8.0% | 0.02% | +10.0% |
| Q3 2019 | $248,000 | -2.4% | 5,801 | -8.6% | 0.02% | -4.8% |
| Q2 2019 | $254,000 | -2.7% | 6,348 | +1.6% | 0.02% | -4.5% |
| Q1 2019 | $261,000 | +39.6% | 6,246 | +27.7% | 0.02% | +22.2% |
| Q4 2018 | $187,000 | -17.3% | 4,891 | -13.1% | 0.02% | -5.3% |
| Q3 2018 | $226,000 | +5.6% | 5,629 | +5.6% | 0.02% | 0.0% |
| Q2 2018 | $214,000 | -7.0% | 5,329 | -9.5% | 0.02% | -13.6% |
| Q1 2018 | $230,000 | -0.9% | 5,888 | -9.9% | 0.02% | 0.0% |
| Q4 2017 | $232,000 | -44.0% | 6,538 | -35.9% | 0.02% | -46.3% |
| Q3 2017 | $414,000 | -40.3% | 10,192 | -36.6% | 0.04% | -42.3% |
| Q2 2017 | $693,000 | -4.4% | 16,071 | -6.5% | 0.07% | -9.0% |
| Q1 2017 | $725,000 | +28.3% | 17,184 | +17.3% | 0.08% | +20.0% |
| Q4 2016 | $565,000 | -11.4% | 14,653 | -0.9% | 0.06% | -18.8% |
| Q3 2016 | $638,000 | +0.5% | 14,785 | +0.9% | 0.08% | -4.8% |
| Q2 2016 | $635,000 | +8.9% | 14,660 | +2.1% | 0.08% | +2.4% |
| Q1 2016 | $583,000 | +6.4% | 14,360 | +5.7% | 0.08% | +3.8% |
| Q4 2015 | $548,000 | +4.4% | 13,585 | -0.4% | 0.08% | -3.7% |
| Q3 2015 | $525,000 | -0.4% | 13,644 | +7.8% | 0.08% | +6.5% |
| Q2 2015 | $527,000 | -10.7% | 12,653 | -1.0% | 0.08% | -10.5% |
| Q1 2015 | $590,000 | -18.4% | 12,783 | -24.5% | 0.09% | -18.1% |
| Q4 2014 | $723,000 | -1.9% | 16,933 | +5.6% | 0.10% | -5.4% |
| Q3 2014 | $737,000 | -17.2% | 16,038 | -3.7% | 0.11% | -19.0% |
| Q2 2014 | $890,000 | +9.2% | 16,648 | +9.1% | 0.14% | +3.0% |
| Q1 2014 | $815,000 | +58.9% | 15,258 | +59.0% | 0.13% | +54.7% |
| Q4 2013 | $513,000 | +63.9% | 9,598 | +53.9% | 0.09% | +50.9% |
| Q3 2013 | $313,000 | +36.7% | 6,235 | +36.2% | 0.06% | +26.7% |
| Q2 2013 | $229,000 | – | 4,578 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |